The Wnt Signaling Pathway and Related Therapeutic Drugs in Autism Spectrum Disorder

키워드

참고문헌 (43)

1. American Psychiatric Association, "American Psychiatric Association. the Diagnostic and Statistical Manual of Mental Disorders 5th edition: DSM-5" (2013), American Psychiatric Publishing
2. clinical psychiatry. 11th ed., "Kaplan and Sadock's synopsis of psychiatry: behavioral science", pp.2015, Sadock BJ
3. Caracci MO, "Synaptic <TEX>$Wnt", GSK3{\beta}$<, Neural Plast, pp.2016, 2016[DOI]
4. Mulligan KA, "Neurodevelopmental perspectives on Wnt signaling in psychiatry", Mol Neuropsychiatry, 2, pp.219~246 (2017)
5. Loh KM, "Generating cellular diversity and spatial form: Wnt signaling and the evolution of multicellular animals", Dev Cell, 38, pp.643~655 (2016)[DOI]
6. Clevers H, "Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control", Science, 346, pp.1248012~ (2014)[DOI]
7. Anastas JN, "WNT signalling pathways as therapeutic targets in cancer", Nat Rev Cancer, 13, pp.11~26 (2013)[DOI]
8. Ather Muneer, "Wnt and GSK3 Signaling Pathways in Bipolar Disorder: Clinical and Therapeutic Implications", Clinical Psychopharmacology and Neuroscience, 15(2), pp.100~114 (2017), 대한정신약물학회[DOI]
9. Nusse R, "Wnt", <TEX>${\beta}$<, Cell, pp.2017, 169[DOI]
10. Daniels DL, "Beta-catenin directly displaces Groucho", TLE repressors from Tcf, Nat Struct Mol Biol, pp.2005, 12[DOI]
11. Martin PM, "A rare WNT1 missense variant overrepresented in ASD leads to increased Wnt signal pathway activation", Transl Psychiatry, 3, pp.e301~ (2013)[DOI]
12. Wassink TH, "Evidence supporting WNT2 as an autism susceptibility gene", Am J Med Genet, 105, pp.406~413 (2001)[DOI]
13. Bonora E, "Mutation screening and association analysis of six candidate genes for autism on chromosome 7q", Eur J Hum Genet, 13, pp.198~207 (2005)[DOI]
14. Benayed R, "Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus", Am J Hum Genet, 77, pp.851~868 (2005)[DOI]
15. Gharani N, "Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder", Mol Psychiatry, 9, pp.474~484 (2004)[DOI]
16. Mohn JL, "Adenomatous polyposis coli protein deletion leads to cognitive and autism-like disabilities", Mol Psychiatry, 19, pp.1133~1142 (2014)[DOI]
17. Krumm N, "A de novo convergence of autism genetics and molecular neuroscience", Trends Neurosci, 37, pp.95~105 (2014)[DOI]
18. Barnard RA, "Mutations and modeling of the chromatin remodeler CHD8 define an emerging autism etiology", Front Neurosci, 9, pp.477~ (2015)
19. Sanders SJ, "First glimpses of the neurobiology of autism spectrum disorder", Curr Opin Genet Dev, 33, pp.80~92 (2015)[DOI]
20. O'Roak BJ, "Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations", Nature, 485, pp.246~250 (2012)[DOI]
21. O'Roak BJ, "Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders", Science, 338, pp.1619~1622 (2012)[DOI]
22. Durak O, "Chd8 mediates cortical neurogenesis via transcriptional regulation of cell cycle and Wnt signaling", Nat Neurosci, 19, pp.1477~1488 (2016)[DOI]
23. Dong F, "Deletion of CTNNB1 in inhibitory circuitry contributes to autism-associated behavioral defects", Hum Mol Genet, 25, pp.2738~2751 (2016)
24. Zhang J, "AKT activation by N-cadherin regulates beta-catenin signaling and neuronal differentiation during cortical development", Neural Dev, 8, pp.7~ (2013)[DOI]
25. Chung RH, "An X chromosome-wide association study in autism families identifies TBL1X as a novel autism spectrum disorder candidate gene in males", Mol Autism, 2, pp.18~ (2011)[DOI]
26. Hong JY, "Shared molecular mechanisms regulate multiple catenin proteins: canonical Wnt signals and components modulate p120-catenin isoform-1 and additional p120 subfamily members", J Cell Sci, 123, pp.4351~4365 (2010)[DOI]
27. Park JI, "Kaiso", p120-catenin and TCF, Dev Cell, pp.2005, 8[DOI]
28. Hong JY, "Down's-syndrome-related kinase Dyrk1A modulates the p120-catenin-Kaiso trajectory of the Wnt signaling pathway", J Cell Sci, 125, pp.561~569 (2012)[DOI]
29. Lu Q, "Genetic alterations of <TEX>${\delta}$<", TEX>-catenin, Neurojungin (CTNND2): functional implications in complex human diseases, pp.Hum Genet, 2016[DOI]
30. Turner TN, "Loss of <TEX>${\delta}$<", TEX>-catenin function in severe autism, 2015, pp.520, 51~56
31. Sowers LP, "Disruption of the non-canonical Wnt gene PRICKLE2 leads to autism-like behaviors with evidence for hippocampal synaptic dysfunction", Mol Psychiatry, 18, pp.1077~1089 (2013)[DOI]
32. Harris KP, "Shank modulates postsynaptic wnt signaling to regulate synaptic development", J Neurosci, 36, pp.5820~5832 (2016)[DOI]
33. Leblond CS, "Meta-analysis of SHANK mutations in autism spectrum disorders: a gradient of severity in cognitive impairments", PLoS Genet, 10, pp.e1004580~ (2014)[DOI]
34. Gauthier J, "Novel de novo SHANK3 mutation in autistic patients", Am J Med Genet B Neuropsychiatr Genet, 150B, pp.421~424 (2009)[DOI]
35. Kwan V, "Wnt signaling networks in autism spectrum disorder and intellectual disability", J Neurodev Disord, 8, pp.45~ (2016)[DOI]
36. Badii Amamou, "Use of Clozapine for Borderline Personality Disorder: A Case Report", Clinical Psychopharmacology and Neuroscience, 14(2), pp.226~228 (2016), 대한정신약물학회
37. Zhou WJ, "The antidepressant roles of Wnt2 and Wnt3 in stress-induced depression-like behaviors", Transl Psychiatry, 6, pp.e892~ (2016)[DOI]
38. Launay JM, "Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16", Transl Psychiatry, 1, pp.e56~ (2011)[DOI]
39. Mines MA, "Brain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice", Cell Signal, 24, pp.1398~1405 (2012)[DOI]
40. 노명선, "Haloperidol and clozapine differentially regulate signalsupstream of glycogen synthase kinase 3 in the rat frontal cortex", Experimental and Molecular Medicine, 39(3), pp.353~360 (2007), 생화학분자생물학회
41. Sutton LP, "Activation of the canonical Wnt pathway by the antipsychotics haloperidol and clozapine involves dishevelled-3", J Neurochem, 102, pp.153~169 (2007)[DOI]
42. Crawley JN, "Autism and cancer share risk genes, pathways and drug targets", Trends Genet, 32, pp.139~146 (2016)[DOI]
43. Kahn M, "Can we safely target the WNT pathway?", Nat Rev Drug Discov, 13, pp.513~532 (2014)[DOI]

관련 논문AI추천